Immunoprecise Antibodies Ltd
XTSX:IPA
Immunoprecise Antibodies Ltd
Depreciation & Amortization
Immunoprecise Antibodies Ltd
Depreciation & Amortization Peer Comparison
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Immunoprecise Antibodies Ltd
XTSX:IPA
|
Depreciation & Amortization
-CA$2.7m
|
CAGR 3-Years
-128%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Abcellera Biologics Inc
NASDAQ:ABCL
|
Depreciation & Amortization
-$24.4m
|
CAGR 3-Years
-72%
|
CAGR 5-Years
-93%
|
CAGR 10-Years
N/A
|
|
Arch Biopartners Inc
XTSX:ARCH
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Replicel Life Sciences Inc
XTSX:RP
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Innovotech Inc
XTSX:IOT
|
Depreciation & Amortization
-CA$6.3k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Immunoprecise Antibodies Ltd's Depreciation & Amortization?
Depreciation & Amortization
-2.7m
CAD
Based on the financial report for Apr 30, 2021, Immunoprecise Antibodies Ltd's Depreciation & Amortization amounts to -2.7m CAD.
What is Immunoprecise Antibodies Ltd's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 3Y
-128%
Over the last year, the Depreciation & Amortization growth was -7%. The average annual Depreciation & Amortization growth rates for Immunoprecise Antibodies Ltd have been -128% over the past three years .